OptiNose (OPTN) Prices 25M Share Offering at $1.60/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
Go back to OptiNose (OPTN) Prices 25M Share Offering at $1.60/sh
November 17, 2021 9:08 AM EST
BMO Capital analyst Gary Nachman lowered the price target on Optinose (NASDAQ: OPTN) to $9.00 (from $16.00) while maintaining an Outperform rating.
The analyst commented, "3Q Xhance revenue was slightly below and 2021 guidance lowered given continued COVID-19 headwinds impacting sales access and Rx volumes (though... More
November 15, 2021 6:02 PM EST
After-Hours Stock Movers:
Beachbody Company (NYSE: BODY) 21% LOWER; reported Q3 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $208.1 million versus the consensus estimate of $246.93 million. Beachbody Company sees FY2021 revenue of $820-830 million, versus the consensus of $964 million.
Axon Enterprise, Inc. (NASDAQ: AXON) 19% HIGHER; reported revenue growth of 39% to $232 million, and GAAP net income of $49 million, which supported Adjusted EBITDA of $51 million, representing a 22% margin. Net income was favorably... More
November 15, 2021 5:41 PM EST
Optinose (NASDAQ: OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All shares of... More
